|
EXOSC10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.431400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.865000E-01 |
| Normal-vs-Stage2 |
6.375100E-03 |
| Normal-vs-Stage3 |
7.127600E-01 |
| Normal-vs-Stage4 |
9.620800E-01 |
| Stage1-vs-Stage2 |
2.038400E-02 |
| Stage1-vs-Stage3 |
5.272400E-01 |
| Stage1-vs-Stage4 |
2.679600E-01 |
| Stage2-vs-Stage3 |
1.551500E-02 |
| Stage2-vs-Stage4 |
5.995100E-03 |
| Stage3-vs-Stage4 |
6.802600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.088000E-01 |
| Normal-vs-AfricanAmerican |
2.178000E-01 |
| Normal-vs-Asian |
5.536800E-01 |
| Caucasian-vs-AfricanAmerican |
1.247800E-01 |
| Caucasian-vs-Asian |
2.604000E-01 |
| AfricanAmerican-vs-Asian |
5.115400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.417600E-01 |
| Normal-vs-Female |
1.822580E-01 |
| Male-vs-Female |
3.800600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.621000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.531000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.285200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.261200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.991400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.157400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.458800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.174200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.237800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.833600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.385990E-01 |
| Classical-VS-Follicular |
9.10982400625926E-12 |
| Classical-VS-Other |
2.675400E-01 |
| Classical-VS-Normal |
5.515800E-01 |
| Tall-VS-Follicular |
1.2469999999265E-07 |
| Tall-VS-Other |
1.195430E-01 |
| Tall-VS-Normal |
9.016300E-02 |
| Follicular-VS-Other |
1.749560E-01 |
| Follicular-VS-Normal |
3.33679999964254E-07 |
| Other-VS-Normal |
3.975400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.358200E-02 |
| Normal-vs-N1 |
5.601200E-01 |
| N0-vs-N1 |
2.415000E-01 |
|
|
